Oxford Immunotec (OXFD) Tops Q2 EPS by 4c

Oxford Immunotec (NASDAQ: OXFD) reported Q2 EPS of ($0.29), $0.04 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $19.2 million versus the consensus estimate of $18.1 million.

GUIDANCE:

Oxford Immunotec sees FY2016 revenue of $82.5-84.5 million, versus prior guidance of $79.5-82.5 million and the consensus of $79.6 million.

For earnings history and earnings-related data on Oxford Immunotec (OXFD) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c